Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

doi:10.1136/annrheumdis-2020-218075

Comment

. 2021 May;80(5):e67.

doi: 10.1136/annrheumdis-2020-218075. Epub 2020 Jun 26.

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Hendrik Schulze-Koops¹, Klaus Krueger², Inka Vallbracht³, Rebecca Hasseli⁴, Alla Skapenko⁵

Affiliations

¹ Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilans University Munich, Munich, Germany hendrik.schulze-koops@med.uni-muenchen.de.
² Praxiszentrum St. Bonifatius, Munich, Germany.
³ Department of Rheumatology, Clinical Immunology and Osteology, München Klinik Bogenhausen, Munich, Germany.
⁴ Department of Rheumatology and Clinical Immunology, Justus-Liebig-University Giessen, Giessen, Germany.
⁵ Division of Rheumatology and Clinical Immunology, Deparmtent of Medicine IV, Ludwig Maximilians University Munich, Munich, Germany.

PMID: 32591357
DOI: 10.1136/annrheumdis-2020-218075

Comment

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Hendrik Schulze-Koops et al. Ann Rheum Dis. 2021 May.

. 2021 May;80(5):e67.

doi: 10.1136/annrheumdis-2020-218075. Epub 2020 Jun 26.

Authors

Hendrik Schulze-Koops¹, Klaus Krueger², Inka Vallbracht³, Rebecca Hasseli⁴, Alla Skapenko⁵

Affiliations

¹ Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilans University Munich, Munich, Germany hendrik.schulze-koops@med.uni-muenchen.de.
² Praxiszentrum St. Bonifatius, Munich, Germany.
³ Department of Rheumatology, Clinical Immunology and Osteology, München Klinik Bogenhausen, Munich, Germany.
⁴ Department of Rheumatology and Clinical Immunology, Justus-Liebig-University Giessen, Giessen, Germany.
⁵ Division of Rheumatology and Clinical Immunology, Deparmtent of Medicine IV, Ludwig Maximilians University Munich, Munich, Germany.

PMID: 32591357
DOI: 10.1136/annrheumdis-2020-218075

No abstract available

Keywords: B-Lymphocytes; arthritis, rheumatoid; rituximab.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al.
Monti S, Montecucco C. Monti S, et al. Ann Rheum Dis. 2021 May;80(5):e68. doi: 10.1136/annrheumdis-2020-218148. Epub 2020 Jun 26. Ann Rheum Dis. 2021. PMID: 32591359 No abstract available.

Comment on

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive _targeted therapies.
Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Monti S, et al. Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.

Cited by

Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.
Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T, Rossi C, Drenou B, Deau Fischer B, Soussain C, Feugier P, Noël N, Choquet S, Bologna S, Joly B, Philippe L, Kohn M, Malak S, Fouquet G, Daguindau E, Taoufik Y, Lacombe K, Cartron G, Thiéblemont C, Besson C. Duléry R, et al. Am J Hematol. 2021 Aug 1;96(8):934-944. doi: 10.1002/ajh.26209. Epub 2021 May 12. Am J Hematol. 2021. PMID: 33909916 Free PMC article.
(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges.
den Broeder AA, den Broeder N, Verhoef LM. den Broeder AA, et al. Rheumatol Adv Pract. 2021 Feb 4;5(1):rkab007. doi: 10.1093/rap/rkab007. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 33693305 Free PMC article. No abstract available.
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C).
Singh N, Madhira V, Hu C, Olex AL, Bergquist T, Fitzgerald KC, Huling JD, Patel RC, Singh JA. Singh N, et al. Semin Arthritis Rheum. 2023 Feb;58:152149. doi: 10.1016/j.semarthrit.2022.152149. Epub 2022 Dec 8. Semin Arthritis Rheum. 2023. PMID: 36516563 Free PMC article.
Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy.
Bektaş M, Özdemir G. Bektaş M, et al. Clin Immunol. 2022 Mar;236:108936. doi: 10.1016/j.clim.2022.108936. Epub 2022 Jan 25. Clin Immunol. 2022. PMID: 35091103 Free PMC article.
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries.
Hasseli R, Hanses F, Stecher M, Specker C, Weise T, Borgmann S, Hasselberger M, Hertenstein B, Hower M, Hoyer BF, Koll C, Krause A, von Lilienfeld-Toal M, Lorenz HM, Merle U, Nunes de Miranda SM, Pletz MW, Regierer AC, Richter JG, Rieg S, Roemmele C, Ruethrich MM, Schmeiser T, Schulze-Koops H, Strangfeld A, Vehreschild MJGT, Voit F, Voll RE, Vehreschild JJ, Müller-Ladner U, Pfeil A. Hasseli R, et al. Front Med (Lausanne). 2024 Mar 6;11:1332716. doi: 10.3389/fmed.2024.1332716. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38510457 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Affiliations

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical